Vice versa, targeting DAMPs, such as HMGB1 and HPSs, with specific blockers can play a vital role in treating inflammatory diseases, such as sepsis, ischemia, myocardial infarction, etc. [110,111]. Here, HMGB1 is linked to myocardial infarction.